ACR acrux limited
Add to My Watchlist 0.00% ! 1.6¢

We are expecting ACR to make significant progress towards...

  1. colourofmoney
    1,368 Posts.
    clock Created with Sketch.
    14/09/09
    20:59
    Post #: 5640644
    We are expecting ACR to make significant progress towards commercialising its male testosterone replacement lotion, Axiron, in the next six-to-12 months. This could result in a major upward re-rating of ACR and a stronger share price.

    http://www.thebull.com.au/articles_detail.php?id=5951
    ACR Price at posting: $1.63 Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS What the hell is wrong with ASX Ltd? The hits keep coming, and now CBOE looms
right-arrow Created with Sketch.
NEWS Iress Ltd leads top gainers intraday Friday as Blackstone buyout bid confirmed
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 32
right-arrow Created with Sketch.
AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
NEWS Expert Exchange: Laretive's 4 key strategies to picking ASX winners
right-arrow Created with Sketch.
NEWS RBA's inflation trick: Is the number lying to us?
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
1.6¢ 		Change
0.000(0.00%) 		Mkt cap ! $6.548M
Open High Low Value Volume
1.6¢ 1.6¢ 1.6¢ $2 103

Buyers (Bids)

No. Vol. Price($)
6 351996 1.6¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 358041 1
View Market Depth
Last trade - 14.28pm 11/08/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.